The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cγ

Molecular and Cellular Biology

Volumn 16, Issue 5, 1996, Pages 2151-2163

  Borrello, Maria Grazia ^a   Alberti, Luisella ^a   Arighi, Elena ^a   Bongarzone, Italia ^a   Battistini, Carlo ^b   Bardelli, Alberto ^c   Pasini, Barbara ^d   Piutti, Claudia ^b   Rizzetti, Maria Grazia ^a   Mondellini, Piera ^a   Radice, Maria Teresa ^a   Pierotti, Marco A ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b PFIZER INC   (United States)

^c UNIVERSITY OF TURIN   (Italy)

^d G GASLINI INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPASE C; TYROSINE;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENICITY; CHROMOSOME REARRANGEMENT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIGAND BINDING; MOUSE; NONHUMAN; ONCOGENE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; THYROID CARCINOMA;

ANIMALIA;

EID: 9244251611     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.16.5.2151     Document Type: Article

References (47)

1. Alonso, T., R. O. Morgan, J. C. Marvizon, H. Zarbl, and E. Santos. 1988. Malignant transformation by ras and other oncogenes produces common alterations in inositol phospholipid signaling pathways. Proc. Natl. Acad. Sci. USA 85:4271-4275.
2. Ben-Levy, R., H. F. Paterson, C. J. Marshall, and Y. Yarden. 1994 A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP kinase pathway. EMBO J. 13:3302-3311
3. Berridge, M. J., J. P. Heslop, R. F. Irvine, and K. D. Brown. 1984 Inositol triphosphate formation and calcium mobilization in Swiss 3T3 cells in response to platelet-derived growth factor. Biochem J. 222:195-201
4. Bongarzone, I., M. G. Butti, S. Coronelli, M. G. Borrello, M. Santoro, P. Mondellini, S. Pilotti, A. Fusco, G. Della Porta, and M. A. Pierotti. 1994. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res. 54:2979-2985.
5. Bongarzone, I., N. Monzini, M. G. Borrello, C. Carcano, G. Ferraresi, E. Arighi, P. Mondellini, G. Della Porta, and M. A. Pierotti. 1993 Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RIα of cyclic AMP-dependent protein kinase A. Mol. Cell. Biol. 13:358-366.
6. Borrello, M. G., G. Pelicci, E. Arighi, L. De Filippis, A. Greco, I. Bongarzone, M. G. Rizzetti, P. G. Pelicci, and M. A. Pierotti. 1994 The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. Oncogene 9:1661-1668.
7. Durick, K., V. J. Yao, M. G. Borrello, J. Bongarzone, M. A. Pierotti, and S. S. Taylor. 1995. Mitogenic activity of RET/ptc2 is due to dimerization via the type 1 regulatory subunit of protein kinase A. J. Biol. Chem 270:24642-24645.
8. ick. Nature (London) 362:87-91.
9. Felder, S., M. Zhou, P. Hu, J. Urena, A. Ullrich, M. Chaudhuri, M. White, S. E. Shoelson, and J. Schlessinger. 1993. SH2 domains exhibit high-affinity binding to tyrosine-phosphorylated peptides yet also exhibit rapid dissociation and exchange. Mol. Cell. Biol 13:1449-1455.
10. Fields, G. B., and R. L. Noble. 1990. Solid phase peptide synthesis utilizing g-fluorenylmethoxycarbonyl amino acids Int. J. Pept. Protein Res 35:161-214.
11. Fixman, E. D., M. A. Naujokas, G. A. Rodrigues, M. F. Moran, and M. Park. 1995. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus. Oncogene 10:237-249.
12. Grieco, M., M. Santoro, M. T. Berlingieri, R. M. Melillo, R. Donghi, I. Bongarzone, M. A. Pierotti, G. Della Porta, A. Fusco, and G. Vecchio. 1990. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60:557-563.
13. Kim, H. K., J. W. Kim, A. Zilberstein, B. Margolis, J. G. Kim, J. Schlessinger, and S. G. Rhee. 1991. PDGF stimulation of inositol phospholipid hydrolysis requires PLC-y1 phosphorylation on tyrosine residues 783 and 1254 Cell 65:435-441.
14. Kitas, E. A., R. Knorr, A. Trzeciak, and W. Bannwarth. 1991. Alternative strategies for the Fmoc solid-phase synthesis of O-phospho-L-tyrosine-containing peptides. Helv. Chim. Acta 74:1314-1328
15. Koch, C. A., D. Anderson, M. F. Moran, C. Ellis, and T. Pawson. 1991 SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252:668-674.
16. Lanzi, C., M. G. Borrello, I. Bongarzone, A. Migliazza, A. Fusco, M. Grieco, M. Santoro, R. A. Gambetta, F. Zunino, G. Della Porta, and M. A. Pierotti. 1992 Identification of the product of two oncogenic rearranged forms of the RET proto-oncogene in papillary thyroid carcinomas Oncogene 7:2189-2194
17. Larose, L., G. Gish, and T. Pawson. 1995. Construction of an SH2 domain-binding with mixed specificity. J. Biol. Chem. 270:3858-3862
18. Martin-Zanca, D., S. H. Hughes, and M. Barbacid. 1986. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature (London) 319:743-748.
19. Mitra, G., D. Martin-Zanca, and M. Barbacid. 1987. Identification and biochemical characterization of p70TRK, product of the human TRK oncogene. Proc Natl Acad. Sci. USA 84:6707-6711
20. Mohammadi, M., C. A. Dionne, W. Li, T. Spivak, A. M. Honegger, M. Jaye, and J. Schlessinger. 1992. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature (London) 358:681.
21. Nishibe, S., M. I. Wahl, S. M. T. Hernandez-Sotomayor, N. K. Tonks, S. G. Rhee, and G. Carpenter. 1990. Increase of the catalytic activity of phospholipase C-gammal by tyrosine phosphorylation. Science 250:1253-1256
22. Nishimura, R., W. Li, A. Kashishian, A. Mondino, M. Zhou, J. Cooper, and J. Schlessinger. 1993. Two signaling molecules share a phosphotyrosine-containing binding site in the platelet-derived growth factor receptor. Mol. Cell. Biol. 13:6889-6896.
23. Obermeier, A., H. Halfter, K. H. Wiesmuller, G. Jung, J. Schlessinger, and A. Ullrich. 1993. Tyrosine 785 is a major determinant of Trk-substrate interaction. EMBO J. 12:933-941.
24. Ohmichi, M., S. J. Decker, L. Pang, and A. R. Saltiel. 1991. Phospholipase C-gam1 directly associates with the p70 TRK oncogene product through its SRC homology domains. J. Biol. Chem. 266:14858-14861.
25. Panayotou, G., G. Gish, P. End, O. Truong, I. Gout, R. Dhand, M. J. Fry, I. Hiles, T. Pawson, and M. D. Waterfield. 1993. Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor β-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach. Mol. Cell Biol. 13:3567-3576.
26. Park, M., M. Dean, C. S. Cooper, M. Schmidt, S. J. O'Brien, D. G. Blair, and G. F. Vande Woude. 1986. Mechanism of met oncogene activation. Cell 45: 895-904.
27. Pasini, B., M. G. Borrello, A. Greco, I. Bongarzone, Y. Luo, P. Mondellini, L. Alberti, C. Miranda, E. Arighi, R. Bocciardi, M. Seri, V. Barone, G. Romeo, and M. A. Pierotti. 1995. Loss of function effect of RET mutations causing Hirschsprung disease. Nature Genet. 10:35-40.
28. Panson, T. 1994. SH2 and SH3 domains in signal transduction. Adv. Cancer Res 64:87.
29. Pawson, T., and J. Schlessinger. 1993. SH2 and SH3 domains. Curr. Biol. 3: 434-442.
30. 2+ flux but not mitogenesis. Nature (London) 358:678.
31. Ponzetto, C., A. Bardelli, F. Maina, P. Longati, G. Panayotou, R. Dhand, M. D. Waterfield, and P. M. Comoglio. 1993. A novel recognition motif for phosphatidylinositol 3-kinase binding mediates its association with the hepatocyte growth factor/scatter factor receptor. Mol. Cell. Biol. 13:4600-4608.
32. Ponzetto, C., A. Bardelli, Z. Zhen, F. Maina, P. dalla Zonca, S. Giordano, A. Graziani, G. Panayotou, and P. M. Comoglio. 1994. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77:261-271.
33. Rodrigues, G. A., and M. Park. 1993. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol. Cell. Biol. 13:6711-6722
34. Santoro, M., R. M. Melillo, M. T. Berlingieri, M. Grieco, G. Vecchio, and A. Fusco. 1993. The TRK and RET tyrosine-kinase oncogenes cooperate with ras in the neoplastic transformation of a rat thyroid epithelial cell line. Cell Growth Differ. 4:77-84.
35. Santoro, M., W. T. Wong, P. Aroca, E. Santos, B. Matoskova, M. Grieco, A. Fusco, and P. P. Di Fiore. 1994. An epidermal growth factor receptor-ret chimera generates mitogenic and transforming signals: evidence for a ret-specific signaling pathway. Mol. Cell. Biol. 14:663-675
36. Smith, M. R., S.-H. Ryu, P.-G. Suh, S.-G. Rhee, and H.-F. Kung. 1989. S-phase induction and transformation of quiescent NIH 3T3 cells by micro-injection of phospholipase C. Proc. Natl. Acad. Sci USA 86:3659-3663.
37. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, B. G. Neel, R. B. Birge, J. E. Fajardo, M. M. Chou, H. Hanafusa, B. Schaffhausen, and L. C. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778.
38. Su, W., W. Liu, B. S. Schaffhausen, and T. M. Roberts. 1995. Association of polyomavirus middle tumor antigen with phospholipase C-gamma1. J. Biol. Chem. 270:12331-12334.
39. Takahashi, M., Y. Buma, T. Iwamoto, Y. Inaguma, H. Ikeda, and H. Hiai. 1988 Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene 3:571-578
40. Turck, C. W., and S. P. Edenson. 1994. Mapping of tyrosine kinase autophosphorylation sites with synthetic peptide substrates Peptide Res 7:140-145.
41. Valius, M., and A. Kazlauskas. 1993. Phospholipase C-gamma1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal Cell 73:321-334
42. van Heyningen, V. 1994. One gene - four syndromes. Nature (London) 367: 319-320.
43. van Weering, D. H. J., J. P. Medema, A. van Puijenbroek, B. M. T. Burgering, P. D. Baas, and J. L. Bos. 1995. Ret receptor tyrosine kinase activates extracellular signal-regulated kinase 2 in SK-N-MC cells. Oncogene 11: 2207-2214.
44. Vetter, M. L., D. Martin-Zanca, L. F. Parada, J. M. Bishop, and D. R. Kaptun. 1991. Nerve growth factor rapidly stimulates tyrosine phosphorylation of phospholipase C-gammaI by a kinase activity associated with the product of the trk protooncogene. Proc Natl. Acad. Sci. USA 88:5650-5654
45. Waksman, G., S. Shoelson, N. Pant, D. Cowburn, and J. Kuriyan. 1993. Binding of a high affinity phosphotyrosyl peptide in the src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell 72:779-790.
46. Wigler, M., S. Silverstein, L. S. Lee, A. Pellicer, Y. Cheng, and R. Axel. 1977. Transfer of purified herpes virus thymidine kinase gene to cultured mouse cells. Cell 11:223-232.
47. Yokote, K., S. Mori, K. Hansen, J. McGlade, T. Pawson, C. H. Heldin, and I., Claesson-Welsh. 1994. Direct interaction between Shc and the platelet-derived growth factor beta-receptor J Biol. Chem. 269:15337-15343.